Asian Star Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:37 pm

Quick Insight

Asian Star Company Ltd, operating in the gems, jewelry, and precious metals industry, currently presents a mixed financial picture. With a share price of ₹740 and a market capitalization of ₹1,184 Cr., the company's P/E ratio stands at 27.4, indicating potential overvaluation compared to its industry peers. Despite a low ROE of 2.82% and ROCE of 4.16%, the company maintains a healthy OPM of 0.54%. However, the high level of borrowings at ₹528 Cr. raises concerns about its financial leverage. Additionally, the P/BV ratio of 0.74x suggests the stock may be undervalued based on its book value. Investors should closely monitor the company's ability to improve profitability and reduce debt levels to unlock long-term value in this competitive sector.

Competitors of Asian Star Company Ltd

All Competitor Stocks of Asian Star Company Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:53 am

Below is a detailed analysis of the quarterly data for Asian Star Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 854.31 Cr.. The value appears strong and on an upward trend. It has increased from 688.25 Cr. (Dec 2024) to 854.31 Cr., marking an increase of 166.06 Cr..
• For Expenses, as of Mar 2025, the value is 849.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 665.63 Cr. (Dec 2024) to 849.69 Cr., marking an increase of 184.06 Cr..
• For Operating Profit, as of Mar 2025, the value is 4.62 Cr.. The value appears to be declining and may need further review. It has decreased from 22.62 Cr. (Dec 2024) to 4.62 Cr., marking a decrease of 18.00 Cr..
• For OPM %, as of Mar 2025, the value is 0.54%. The value appears to be declining and may need further review. It has decreased from 3.29% (Dec 2024) to 0.54%, marking a decrease of 2.75%.
• For Other Income, as of Mar 2025, the value is -0.92 Cr.. The value appears to be declining and may need further review. It has decreased from 3.67 Cr. (Dec 2024) to -0.92 Cr., marking a decrease of 4.59 Cr..
• For Interest, as of Mar 2025, the value is 6.92 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.54 Cr. (Dec 2024) to 6.92 Cr., marking a decrease of 0.62 Cr..
• For Depreciation, as of Mar 2025, the value is 1.85 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.05 Cr. (Dec 2024) to 1.85 Cr., marking a decrease of 1.20 Cr..
• For Profit before tax, as of Mar 2025, the value is -5.07 Cr.. The value appears to be declining and may need further review. It has decreased from 15.70 Cr. (Dec 2024) to -5.07 Cr., marking a decrease of 20.77 Cr..
• For Tax %, as of Mar 2025, the value is 20.91%. The value appears to be improving (decreasing) as expected. It has decreased from 28.98% (Dec 2024) to 20.91%, marking a decrease of 8.07%.
• For Net Profit, as of Mar 2025, the value is -6.13 Cr.. The value appears to be declining and may need further review. It has decreased from 11.15 Cr. (Dec 2024) to -6.13 Cr., marking a decrease of 17.28 Cr..
• For EPS in Rs, as of Mar 2025, the value is -2.80. The value appears to be declining and may need further review. It has decreased from 7.52 (Dec 2024) to -2.80, marking a decrease of 10.32.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:49 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:49 pm

Below is a detailed analysis of the balance sheet data for Asian Star Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,546.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,493.00 Cr. (Mar 2024) to 1,546.00 Cr., marking an increase of 53.00 Cr..
• For Borrowings, as of Mar 2025, the value is 528.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 741.00 Cr. (Mar 2024) to 528.00 Cr., marking a decrease of 213.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 318.00 Cr.. The value appears to be improving (decreasing). It has decreased from 462.00 Cr. (Mar 2024) to 318.00 Cr., marking a decrease of 144.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,408.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,713.00 Cr. (Mar 2024) to 2,408.00 Cr., marking a decrease of 305.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 213.00 Cr.. The value appears to be declining and may need further review. It has decreased from 223.00 Cr. (Mar 2024) to 213.00 Cr., marking a decrease of 10.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 80.00 Cr. (Mar 2024) to 79.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,410.00 Cr. (Mar 2024) to 2,116.00 Cr., marking a decrease of 294.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,408.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,713.00 Cr. (Mar 2024) to 2,408.00 Cr., marking a decrease of 305.00 Cr..

Notably, the Reserves (1,546.00 Cr.) exceed the Borrowings (528.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Asian Star Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 26.98. This value is within the healthy range. It has decreased from 48.25 (Mar 24) to 26.98, marking a decrease of 21.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is 26.98. This value is within the healthy range. It has decreased from 48.25 (Mar 24) to 26.98, marking a decrease of 21.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 32.82. This value is within the healthy range. It has decreased from 55.87 (Mar 24) to 32.82, marking a decrease of 23.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 975.87. It has increased from 942.69 (Mar 24) to 975.87, marking an increase of 33.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 975.87. It has increased from 942.69 (Mar 24) to 975.87, marking an increase of 33.18.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,846.56. It has decreased from 2,201.12 (Mar 24) to 1,846.56, marking a decrease of 354.56.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 63.36. This value is within the healthy range. It has decreased from 91.57 (Mar 24) to 63.36, marking a decrease of 28.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 56.47. This value is within the healthy range. It has decreased from 84.16 (Mar 24) to 56.47, marking a decrease of 27.69.
• For PBT / Share (Rs.), as of Mar 25, the value is 33.82. This value is within the healthy range. It has decreased from 60.66 (Mar 24) to 33.82, marking a decrease of 26.84.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 25.93. This value is within the healthy range. It has decreased from 48.47 (Mar 24) to 25.93, marking a decrease of 22.54.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 26.98. This value is within the healthy range. It has decreased from 48.25 (Mar 24) to 26.98, marking a decrease of 21.27.
• For PBDIT Margin (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 10. It has decreased from 4.16 (Mar 24) to 3.43, marking a decrease of 0.73.
• For PBIT Margin (%), as of Mar 25, the value is 3.05. This value is below the healthy minimum of 10. It has decreased from 3.82 (Mar 24) to 3.05, marking a decrease of 0.77.
• For PBT Margin (%), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 10. It has decreased from 2.75 (Mar 24) to 1.83, marking a decrease of 0.92.
• For Net Profit Margin (%), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 5. It has decreased from 2.20 (Mar 24) to 1.40, marking a decrease of 0.80.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 8. It has decreased from 2.19 (Mar 24) to 1.46, marking a decrease of 0.73.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 15. It has decreased from 5.10 (Mar 24) to 2.76, marking a decrease of 2.34.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.42. This value is below the healthy minimum of 10. It has decreased from 8.33 (Mar 24) to 5.42, marking a decrease of 2.91.
• For Return On Assets (%), as of Mar 25, the value is 1.79. This value is below the healthy minimum of 5. It has decreased from 2.84 (Mar 24) to 1.79, marking a decrease of 1.05.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has decreased from 0.49 (Mar 24) to 0.33, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.15. It has decreased from 1.35 (Mar 24) to 1.15, marking a decrease of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.25 (Mar 24) to 3.01, marking an increase of 0.76.
• For Quick Ratio (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has increased from 1.41 (Mar 24) to 2.00, marking an increase of 0.59.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 2.23 (Mar 24) to 2.79, marking an increase of 0.56.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.10 (Mar 24) to 0.00, marking a decrease of 3.10.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.69 (Mar 24) to 0.00, marking a decrease of 2.69.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.90 (Mar 24) to 0.00, marking a decrease of 96.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.31 (Mar 24) to 0.00, marking a decrease of 97.31.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.01. This value is within the healthy range. It has decreased from 3.90 (Mar 24) to 3.01, marking a decrease of 0.89.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 24) to 2.31, marking a decrease of 0.75.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,378.89. It has decreased from 1,625.90 (Mar 24) to 1,378.89, marking a decrease of 247.01.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.46.
• For EV / EBITDA (X), as of Mar 25, the value is 13.60. This value is within the healthy range. It has increased from 11.09 (Mar 24) to 13.60, marking an increase of 2.51.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.39, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.89 (Mar 24) to 0.00, marking a decrease of 96.89.
• For Price / BV (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.74, marking a decrease of 0.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.39, marking an increase of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness